We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

52 hedge funds and large institutions have $16M invested in Perspective Therapeutics in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $9.99M → $16M (+$6.03M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

6% more funds holding

Funds holding: 49 → 52 (+3)

0% more ownership

Funds ownership: 1.3% → 1.31% (+0%)

Holders
52
Holders Change
+3
Holders Change %
+6.12%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$450K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$111K
3
HighTower Advisors
HighTower Advisors
Illinois
+$52.1K
4
PIC
Portland Investment Counsel
Ontario, Canada
+$40.1K
5
Morgan Stanley
Morgan Stanley
New York
+$16K

Top Sellers

Rank Fund Capital Flow
1
PCM
Perkins Capital Management
Minnesota
-$555K
2
Jane Street
Jane Street
New York
-$37.7K
3
HF
HRT Financial
New York
-$23.2K
4
TSS
Two Sigma Securities
New York
-$21K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
-$17.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.31M +$111K +39,512 +3%
BBA
2
Baker Bros. Advisors
New York
$3.07M – – –
BlackRock
3
BlackRock
New York
$1.82M – – –
RAG
4
RIA Advisory Group
Iowa
$1.28M +$2.13K +756 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.01M – – –
GTC
6
Ghost Tree Capital
New York
$643K +$450K +160,000 New
OCM
7
Osterweis Capital Management
California
$636K – – –
HighTower Advisors
8
HighTower Advisors
Illinois
$536K +$52.1K +18,520 +16%
PCM
9
Perkins Capital Management
Minnesota
$281K -$555K -197,164 -74%
State Street
10
State Street
Massachusetts
$270K – – –
TMWM
11
Taylor & Morgan Wealth Management
Michigan
$251K +$14.1K +5,000 +9%
Northern Trust
12
Northern Trust
Illinois
$158K – – –
Renaissance Technologies
13
Renaissance Technologies
New York
$123K -$17.1K -6,090 -17%
BCM
14
Bridgeway Capital Management
Texas
$74K – – –
Bank of New York Mellon
15
Bank of New York Mellon
New York
$62K – – –
PIC
16
Portland Investment Counsel
Ontario, Canada
$57K +$40.1K +14,255 New
Creative Planning
17
Creative Planning
Kansas
$55.7K +$2.53K +900 +7%
WE
18
Wealth Effects
Massachusetts
$48.2K +$2.81K +1,000 +9%
Charles Schwab
19
Charles Schwab
California
$46.6K – – –
Morgan Stanley
20
Morgan Stanley
New York
$45.8K +$16K +5,696 +100%
HAG
21
HighPoint Advisor Group
Illinois
$20K +$4.42K +1,570 New
Mariner
22
Mariner
Kansas
$19.2K +$13.4K +4,778 New
Commonwealth Equity Services
23
Commonwealth Equity Services
Massachusetts
$17K – – –
ACM
24
ADAR1 Capital Management
Texas
$17K +$11.9K +4,220 New
Cerity Partners
25
Cerity Partners
New York
$16.1K +$11.3K +4,000 New
1
2 3

CATX Hedge Fund Activity: Q4 2023 in Review

52 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2023, worth a combined $16M — up 60% from $9.99M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CATX positions and 8 closed out — a net gain of 3 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $450K. The largest seller was Perkins Capital Management, cutting an estimated $555K.

  • 52 institutional investors held Perspective Therapeutics (CATX) as of Q4 2023, up from 49 in Q3 2023.
  • Funds reported $16M of Perspective Therapeutics stock for Q4 2023, up 60% quarter-over-quarter.
  • 11 funds opened new Perspective Therapeutics positions in Q4 2023 and 8 closed out, a net change of +3 holders.
  • The largest Perspective Therapeutics buyer in Q4 2023 was Ghost Tree Capital, an estimated $450K added.
  • The largest Perspective Therapeutics seller in Q4 2023 was Perkins Capital Management, an estimated $555K sold.

Based on aggregated 13F filings for Q4 2023.